Oncternal Therapeutics Inc ONCT:NASDAQ

Last Price$1.16NASDAQ Previous Close - Last Trade as of 4:00PM ET 8/12/22

Today's Change+0.03(2.65%)
Bid (Size)$1.17 (41)
Ask (Size)$1.18 (4)
Day Low / High$1.09 - 1.17
Volume1.1 M
  • Latest Stories
  • Commentary and Analysis
Oncternal Therapeutics to Work With AbbVie Unit On Mantle Cell Lymphoma Clinical Trial; Shares Rise After Hours
4:24PM ET 7/14/2022 MT Newswires

Oncternal Therapeutics (ONCT) said late Thursday it entered into a collaboration with AbbVie's (ABBV) Pharmacyclics unit that includes supply of ibrutinib...

--Maxim Initiates Oncternal Therapeutics at Buy, Sets Price Target at $3.50
10:45AM ET 5/10/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Oncternal Therapeutics Shifts Priority to Zilovertamab From ONCT-216; Shares Fall
10:02AM ET 4/13/2022 MT Newswires

Oncternal Therapeutics (ONCT) said Wednesday that it has deprioritized the development of ONCT-216 to reallocate resources to zilovertamab, which is...

-- Earnings Flash (ONCT) ONCTERNAL THERAPEUTICS Reports Q4 Loss $-0.16, vs. Street Est of $-0.25
4:03PM ET 3/10/2022 MT Newswires

...

--BTIG Starts Oncternal Therapeutics at Buy With $5 Price Target
6:39AM ET 2/24/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

After Hours Watch List Scorecard: WEJO, ONCT, SWIM
5:23PM ET 1/05/2022 MT Newswires

Here's how the stocks on Tuesday's After Hours Watch List performed during today's regular session: AFTER HOURS REGULAR SESSION WEJO +27.8% ...

MT Newswires After Hours Watch List: WEJO, ONCT, SWIM
5:43PM ET 1/04/2022 MT Newswires

Here are some of the stocks moving in after-hours trading worth watching in Wednesday's regular session: WEJO:+27.8%; Says developing vehicle data...

Oncternal Therapeutics Finalizes Study Design for Late-Stage Mantle Cell Lymphoma Trial -- Stock Jumps After-Hours
4:30PM ET 1/04/2022 MT Newswires

Oncternal Therapeutics (ONCT) said late Tuesday it has agreed with the US Food and Drug Administration a study design and "major details" of a phase 3...

Oncternal Therapeutics' Potential Prostate Cancer Drug Shows Anti-Tumor Activity in Preclinical Trials
4:31PM ET 10/05/2021 MT Newswires

Oncternal Therapeutics (ONCT) said Tuesday its drug candidate ONCT-534 has shown anti-tumor activity in a series of pre-clinical studies and may become a...

Oncternal, Celularity Collaborating on Targeted Placental-Derived Cellular Therapies
10:31AM ET 9/20/2021 MT Newswires

Oncternal Therapeutics (ONCT) and Celularity (CELU) said Monday they entered a research partnership to evaluate placental derived-cellular therapies...